MedTrace Logo

DNA-based Testing in BAL of Lung Transplant Recipients With Suspected Non-viral Lower Respiratory Tract Infection

NCT02568358 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2015-10-05

No results posted yet for this study

Summary

Lung transplantation (LTx) , DNA-based testing.

Performance of DNA-based testing of bacterial and fungal pathogens in comparison to standard testing.

Experimental intervention: DNA-based testing of BAL fluid.

Conditions

  • Lower Respiratory Tract and Lung Infections

Interventions

OTHER

Experimental Intervention: DNA-based testing of BAL fluid

DNA based testing needs 4.5 hours lab time in addition to standard testing

Sponsors & Collaborators

  • Hannover Medical School

    lead OTHER

Principal Investigators

  • Jens Gottlieb, Prof. Dr. · Hannover Medical School

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-04-30
Completion
2016-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02568358 on ClinicalTrials.gov